Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation A Randomized Controlled Trial
Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: JAMA
Author: David Gonzales
Institution: Oregon Health & Science University
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2107200746
